Emil D. Kakkis

President and Chief Executive Officer, Director

CEO Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Ultragenyx Pharmaceutical Inc. (RARE)	M.D., Ph.D. President and Chief Executive Officer	$861,100	—	$8,364,938	$1,847,356	$299,663	$32,478	$11,405,535
2024	Ultragenyx Pharmaceutical Inc. (RARE)	M.D., Ph.D. President and Chief Executive Officer	$856,008	—	$9,374,511	$2,715,600	$757,768	$13,800	$13,717,687
2023	Ultragenyx Pharmaceutical Inc. (RARE)	M.D., Ph.D. President and Chief Executive Officer	$823,692	—	$9,456,663	$2,161,782	$622,656	$13,200	$13,077,993
2022	Ultragenyx Pharmaceutical Inc. (RARE)	M.D., Ph.D. President and Chief Executive Officer	$796,154	—	$7,463,295	$3,310,681	$558,000	$12,200	$12,140,330
2021	Ultragenyx Pharmaceutical Inc. (RARE)	M.D., Ph.D. President and Chief Executive Officer	$768,846	—	$5,410,512	$2,835,580	$499,100	$8,700	$9,522,738
2020	Ultragenyx Pharmaceutical Inc. (RARE)	M.D., Ph.D. President and Chief Executive Officer	$759,231	—	$1,906,720	$1,802,869	$668,850	$6,550	$5,144,220
2019	Ultragenyx Pharmaceutical Inc. (RARE)	M.D., Ph.D. President and Chief Executive Officer	$714,000	—	$2,702,000	$2,650,784	$479,808	$6,550	$6,553,142
2018	Ultragenyx Pharmaceutical Inc. (RARE)	M.D., Ph.D. President and Chief Executive Officer	$679,952	—	$944,385	$2,753,513	$428,400	$39,377	$4,845,627
2017	Ultragenyx Pharmaceutical Inc. (RARE)	M.D., Ph.D. President and Chief Executive Officer	$638,115	—	$1,319,303	$4,295,234	$393,000	$39,247	$6,684,899

Executive changes

Appointed Class I Director at Ultragenyx Pharmaceutical Inc. (RARE)
2026-05-14

Earnings-call appearances

No earnings-call appearances recorded yet.